medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 18, 2023
Abstract
Background
and
Hypothesis
Previous
studies
have
suggested
that
choroid
plexus
(ChP)
enlargement
occurs
in
individuals
with
schizophrenia-spectrum
disorders
(SSD)
is
associated
peripheral
inflammation.
However,
it
unclear
whether
such
an
delineates
a
biologically
defined
subgroup
of
SSD.
Moreover,
remains
elusive
how
ChP
linked
to
brain
regions,
inflammation
Study
Design
A
cross-sectional
cohort
132
SSD
107
age-matched
healthy
controls
(HC)
underwent
magnetic
resonance
imaging
(MRI)
the
clinical
phenotyping
investigate
regions.
Case-control
comparison
volumes
was
conducted
structural
variance
analysed
by
employing
variability
ratio
(VR).
K-means
clustering
analysis
used
identify
subgroups
distinct
patterns
ventricular
system
clusters
were
compared
terms
demographic,
immunological
measures.
The
relationship
between
previously
inflammation,
investigated.
Results
We
could
not
find
significant
HC
but
detected
increased
VR
lateral
ventricle
volumes.
Based
on
these
regions
we
identified
3
differences
age,
symbol
coding
test
scores
possibly
inflammatory
markers.
Larger
volume
higher
hippocampus,
putamen,
thalamus
SSD,
HC.
Conclusions
This
study
suggests
variability,
mean
volume,
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(5), P. 488 - 488
Published: May 3, 2024
Interleukin-8
(IL-8/CXCL8),
an
essential
CXC
chemokine,
significantly
influences
psychoneuroimmunological
processes
and
affects
neurological
psychiatric
health.
It
exerts
a
profound
effect
on
immune
cell
activation
brain
function,
suggesting
potential
roles
in
both
neuroprotection
neuroinflammation.
IL-8
production
is
stimulated
by
several
factors,
including
reactive
oxygen
species
(ROS)
known
to
promote
inflammation
disease
progression.
Additionally,
CXCL8
gene
polymorphisms
can
alter
production,
leading
differences
susceptibility,
progression,
severity
across
populations.
levels
vary
among
neuropsychiatric
conditions,
demonstrating
sensitivity
psychosocial
stressors
severity.
be
detected
blood
circulation,
cerebrospinal
fluid
(CSF),
urine,
making
it
promising
candidate
for
broad-spectrum
biomarker.
This
review
highlights
the
need
further
research
diverse
effects
of
associated
implications
personalized
medicine.
A
thorough
understanding
its
complex
role
could
lead
development
more
effective
treatment
strategies
conditions.
Brain Behavior and Immunity,
Journal Year:
2024,
Volume and Issue:
120, P. 430 - 438
Published: June 17, 2024
Recent
studies
have
associated
immune
abnormalities
with
dementia.
IL-6
is
a
crucial
cytokine
in
inflammatory
responses,
and
recent
evidence
has
linked
elevated
levels
to
changes
brain
structure
cognitive
decline.
However,
the
connection
between
levels,
cognition,
volumes,
dementia
risk
requires
exploration
large
prospective
cohorts.
Schizophrenia,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: July 10, 2024
Abstract
The
tryptophan-metabolizing
kynurenine
pathway
(KP)
can
be
activated
by
enhanced
inflammatory
responses
and
has
been
implicated
in
the
pathophysiology
of
schizophrenia.
However,
there
is
little
evidence
for
KP
dysregulation
early
course
psychotic
illness.
We
aimed
to
investigate
potential
immune-mediated
hyperactivity
individuals
with
first-episode
psychosis
(FEP)
relationship
symptom
severity
treatment
response
outcomes.
Serum
immunoassays
were
performed
measure
peripheral
levels
cytokines
(IL-1β,
IL-10,
TNF-a),
rate-limiting
enzymes
(IDO/TDO),
kynurenic
acid
(KYNA)
metabolite
104
antipsychotic-naïve
patients
FEP
80
healthy
controls
(HC).
Positive
Negative
Syndrome
Scale
(PANSS)
Global
Assessment
Functioning
(GAF)
administered
assess
psychopathology
functioning
status
at
admission
following
4-week
antipsychotics.
Cytokine
components
substantially
increased
compared
HC,
before
after
antipsychotic
treatment.
A
significant
positive
correlation
between
pro-inflammatory
IL-1β
KYNA
was
observed
among
patients,
but
not
HC.
Importantly,
within-patient
analysis
revealed
that
those
higher
baseline
experienced
more
severe
negative
symptoms
poorer
clinical
improvement
follow-up.
These
findings
suggest
upregulated
psychosis,
likely
through
induction
IL-1β-dependent
pathways,
raised
might
represent
a
promising
indicator
non-response
medication
FEP.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(7), P. 763 - 763
Published: July 18, 2024
Schizophrenia
is
a
neuropsychiatric
disorder
affecting
approximately
1
in
300
people
worldwide.
It
characterized
by
range
of
symptoms,
including
positive
symptoms
(delusions,
hallucinations,
and
formal
thought
disorganization),
negative
(anhedonia,
alogia,
avolition,
asociality,
blunted
affect),
cognitive
impairments
(impaired
memory,
attention,
executive
function,
processing
speed).
Current
treatments,
such
as
psychopharmacology
psychotherapy,
often
do
not
fully
address
these
leading
to
impaired
everyday
functionality.
In
recent
years,
there
has
been
growing
interest
neuromodulation
due
computer
engineering
science
making
extraordinary
computational
advances.
Those
put
together
have
reinitiated
the
spark
field
neurofeedback
(NF)
means
for
self-regulation
with
potential
alleviate
daily
burden
schizophrenia.
We
review,
systematic
way,
primary
reports
electroencephalogram
(EEG)-based
NF
therapeutical
tool
The
main
body
research
consists
mostly
case
studies
reports.
results
few
randomized
controlled
studies,
combined
studies/series,
underscore
use
an
add-on
treatment
option
improving
lives
suffering
individuals,
being
sustained
changes
brain
function
symptomatology
improvement.
aim
provide
important
evidence
using
patients
schizophrenia,
summarizing
effects
conclusions
found
several
clinical
trials.
Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
15
Published: April 29, 2024
Background
Chronic
and
acute
inflammation
of
the
mucosa-associated
lymphoid
tissue
have
been
positively
linked
to
development
psychiatric
disorders
in
observational
studies.
However,
it
remains
unclear
whether
this
association
is
causal.
In
present
study,
we
investigated
association,
using
as
proxies
genetically
predicted
tonsillectomy,
appendectomy
appendicitis
on
including
major
depressive
disorder
(MDD),
schizophrenia
(SCZ),
bipolar
depression
(BD)
anxiety
(ANX)
via
a
two-sample
Mendelian
randomization
(MR)
analysis.
Methods
Genetic
summary
statistics
for
were
sourced
from
FinnGen
Consortium,
comprising
data
342,000
participants.
correlations
between
all
exposures
outcome
calculated
with
Linkage
Disequilibrium
Score
(LDSC)
Regression
MR
estimates
then
assess
their
impact
risk
developing
disorders.
Sensitivity
analysis
was
employed
test
any
directional
pleiotropy.
Results
Our
results
suggest
that
there
no
direct
causal
or
heightened
The
robustness
main
further
confirmed
additional
sensitivity
analyses.
moderate
inverse
genetic
correlation
observed
tonsillectomy
MDD
traits
(r
g
=-0.39,
p-value
(P)=7.5x10
-5
).
Conclusion
findings
provide,
first
time,
evidence
subsequent
vulnerability
Future
studies
larger
sample
size
GWAS
should
focus
unraveling
confounding
factors
mediators
investigate
relationship
further.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
15(1), P. 10 - 10
Published: Dec. 25, 2024
Schizophrenia
is
a
complex
heterogenous
disorder
thought
to
be
caused
by
interactions
between
genetic
and
environmental
factors.
The
theories
developed
explain
the
etiology
of
schizophrenia
have
focused
largely
on
dysfunction
neurotransmitters
such
as
dopamine,
serotonin
glutamate
with
their
receptors,
although
research
in
past
several
decades
has
indicated
strongly
that
other
factors
are
also
involved
role
neuroglial
cells
psychotic
disorders
including
should
given
more
attention.
Although
glia
were
originally
present
brain
only
support
neurons
physical,
metabolic
nutritional
capacity,
it
become
apparent
these
variety
important
physiological
roles
abnormalities
function
may
make
significant
contributions
symptoms
schizophrenia.
In
paper,
we
review
microglia,
astrocytes
oligodendroglia
aspects
transmitter
dysregulation,
neuro-inflammation,
oxidative
stress,
synaptic
function,
gut
microbiome,
myelination
blood-brain
barrier
appear
affect
cause,
development
treatment
We
crosstalk
oligodendrocytes
effects
antipsychotics
neuroglia.
Problems
associated
studies
specific
biomarkers
for
discussed.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 1, 2024
Abstract
Psychotic
disorder
is
associated
with
altered
levels
of
various
inflammatory
markers
in
blood,
but
existing
studies
have
typically
focused
on
a
few
selected
biomarkers,
not
examined
specific
symptom
domains
notably
negative
symptoms,
and
are
based
individuals
established/chronic
illness.
Based
data
from
young
people
aged
24
years
the
Avon
Longitudinal
Study
Parents
Children
(ALSPAC),
UK
birth
cohort,
we
associations
67
plasma
immune/inflammatory
proteins
assayed
using
Olink
Target
96
Inflammation
panel
psychotic
disorder,
positive
(any
experiences
definite
experiences)
linear
models
empirical
Bayes
estimation.
The
analyses
included
between
2641
2854
individuals.
After
adjustment
for
age,
sex,
body
mass
index
smoking
correction
multiple
testing,
upregulation
CDCP1
IL-6
were
consistently
symptoms
while
was
additionally
MMP-10.
Negative
highest
number
(n=11),
including
cytokines,
chemokines
growth
factors
which
partly
overlap
or
(CDCP1,
MMP-10).
Our
findings
highlight
involved
immune
regulation,
cell
activation/migration,
blood-brain
barrier
disruption,
extracellular
matrix
abnormalities
psychosis
people,
consistent
role
inflammation
dysfunction
pathogenesis
disorders.
Journal of Affective Disorders Reports,
Journal Year:
2024,
Volume and Issue:
17, P. 100828 - 100828
Published: July 1, 2024
The
neuroinflammatory
hypothesis
of
Major
Depressive
Disorder
(MDD)
postulates
that
dysregulated
cytokine
production
is
implicated
in
the
etiopathology
disorder.
This
study
aimed
to
determine
baseline
levels
Interleukin-8
(IL-8),
an
inflammatory
cytokine,
MDD
and
identify
possible
changes
response
antidepressant
drug
therapy.
Two
independent
groups
patients
who
met
criteria
were
enrolled;
one
group
was
treated
with
Escitalopram
other
Quetiapine
for
twelve
weeks.
There
a
healthy
control
(HC)
group.
In
30
completed
visit
43
patients.
Plasma
concentrations
IL-8
measured
at
baseline,
week
eight,
12
treatment.
correlated
depression
severity
12.
sample
size
analysis
17
completers
study,
21
19
HCs.
We
used
Student's
t-test
Pearson
Correlation
Coefficient
statistical
analyses.
exhibited
elevated
compared
controls
(p
=
0.007).
However,
did
not
show
significant
reduction
after
weeks
treatment
significantly
either
or
there
notable
downtrend
both
though
statistically
significant.
Study
limitations
include
variations
power,
length.
No
formal
assessment
conducted
rule
out
Axis
II
diagnoses.
These
findings
underscore
relationship
between
MDD,
suggesting
may
play
role
pathophysiology
but
its
requires
prolonged
period
suggests
as
pro-inflammatory
biomarker,
while
lack
immediate
normalization
post-treatment
indicates
need
further
exploration
delayed
effects
therapy
on
immune
markers
IL-8′s
mechanism
action
specific
pharmacotherapies
MDD.